Beijing 302 Hospital
Clinical trials sponsored by Beijing 302 Hospital, explained in plain language.
-
Radical Two-Part cell transplant trial offers hope for leukemia patients out of options
Disease control Recruiting nowThis early-phase study is testing a new two-step approach for patients with leukemia that has come back or not responded to standard treatments. First, patients receive chemotherapy and an infusion of immune cells from a partially matched donor to try to reduce the cancer. Then, …
Phase: PHASE1 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Experimental cell therapy offers hope for High-Risk blood cancer patients
Disease control Recruiting nowThis study is testing whether adding an infusion of donor immune cells to a standard drug regimen is safe and effective for treating intermediate- to high-risk myelodysplastic syndromes (MDS), a type of bone marrow cancer. It is for patients who cannot receive a standard stem cel…
Phase: PHASE2 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Zap to relax? electrical skin patches tested to ease medical procedure
Symptom relief Recruiting nowThis study is testing if a non-invasive therapy using mild electrical stimulation on specific skin points can help patients better tolerate a complex digestive procedure called ERCP. Researchers want to see if this method, used alongside standard sedative drugs, reduces side effe…
Phase: NA • Sponsor: Beijing 302 Hospital • Aim: Symptom relief
Last updated Mar 11, 2026 14:53 UTC